Share This Page
Drug Price Trends for NDC 64980-0351
✉ Email this page to a colleague
Average Pharmacy Cost for 64980-0351
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FAMCICLOVIR 500 MG TABLET | 64980-0351-03 | 0.83956 | EACH | 2025-11-19 |
| FAMCICLOVIR 500 MG TABLET | 64980-0351-03 | 0.80320 | EACH | 2025-10-22 |
| FAMCICLOVIR 500 MG TABLET | 64980-0351-03 | 0.76770 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 64980-0351
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 64980-0351
Introduction
NDC 64980-0351 identifies a specific pharmaceutical product within the United States drug distribution system. As a dominant component in the pharmaceutical supply chain, understanding its market landscape, competitive positioning, and projected pricing is essential for stakeholders including manufacturers, payers, and investors. This analysis dissects the current market environment for this drug, explores factors influencing its price trajectory, and offers strategic insights for decision-making.
Product Overview
NDC 64980-0351 corresponds to [Product Name], a [drug class] used primarily for [indicated conditions]. Approved by the FDA in [Year], the drug has established a significant presence in the treatment landscape, characterized by [notable features, e.g., biologic origin, complex manufacturing, or specialized administration]. Its clinical efficacy and safety profile have driven widespread adoption, influencing its market demand.
Market Landscape
Market Size and Demand Dynamics
The global demand for [drug class] has experienced notable growth, driven by [factors such as rising incidence of indications, advancements in treatment protocols, and unmet medical needs]. In the U.S., the demand for [specific drug] remains robust, supported by [clinical guidelines, reimbursement policies, and physician preference].
The [specific indication or pathway] for [product] projects a compound annual growth rate (CAGR) of [percentage] over the next five years, based on recent epidemiological data and prescribing trends [1]. The uptake is further influenced by [demographic shifts, aging populations, and technological innovations].
Competitive Environment
The competitive landscape comprises [number] primary competitors, including [generic alternatives, biosimilars, or branded rivals]. Notably:
- [Major Competitors] offer [similar or alternative therapies], with competitive advantages in [cost, efficacy, form of administration].
- The entry of biosimilars and generics is anticipated to intensify price competition, pressuring branded prices [2].
- Patent protections and exclusivity periods, such as [patent expiration of key formulations], influence market entry timing for rivals [3].
Regulatory and Reimbursement Factors
Reimbursement policies from CMS and private insurers significantly influence market access and pricing. Expansion of [value-based pricing or prior authorization] can restrict access, impacting overall demand. The trajectory of FDA approvals and potential label expansions also inject volatility and growth opportunities into the market.
Pricing Analysis
Current Pricing Landscape
As of [latest quarter/year], the average wholesale acquisition cost (AWAC) for [product] ranges from $[X] to $[Y], with variations based on dosage, packaging, and supplier negotiations. The retail prices, factoring in rebates and discounts, often compound to $[Z] [4].
Pricing Trends and Drivers
Key factors influencing pricing include:
- Market maturity: As the drug matures into the mainstream, price stabilization occurs.
- Patent status: Patents protect pricing power; expiration leads to competitive downward pressure.
- Manufacturing complexity: High manufacturing costs justify elevated prices.
- Regulatory developments: Deployment of biosimilar entrants can precipitate price declines.
- Reimbursement policies: Shifts toward value-based care could impact gross margins.
Projected Price Trends
Over the next 3-5 years, price projections suggest:
- A modest decline of [percentage]% in wholesale prices due to generic/biosimilar competition [5].
- Alternatively, specialized formulations or delivery methods may sustain or elevate prices, especially in niche markets [6].
- Introduction of [novel indications or improved formulations] could stabilize or increase prices to cover R&D investments.
Influence of Biosimilars and Generics
The upcoming patent expiry scheduled for [year] is expected to catalyze a price reduction of [estimated]%, aligning with trends observed in similar biologics [7]. The market will adjust as biosimilars gain market share, potentially reducing the list prices by [range]%.
Strategic Implications
For Manufacturers
To sustain profitability amidst price erosions, investment in [value-added services, patient support programs, or differentiation strategies] is necessary. The early introduction of biosimilars could also be a strategic move to maintain market share.
For Payers
Negotiation leverage will intensify as multiple competitors emerge. Payers should strategize around formulary placement and value-based contracts to optimize coverage and reduce out-of-pocket costs.
For Investors
Monitoring patent status, regulatory approvals, and market adoption rates is crucial. Anticipate potential mitigators—such as pipeline developments or regulatory hurdles—that could affect future pricing and revenue streams.
Regulatory Outlook and Market Risks
Regulatory landscapes are evolving, with increased emphasis on biosimilar approval pathways and post-market surveillance. Risks include:
- Delays in biosimilar approvals
- Reimbursement rate adjustments
- Emergence of new therapies or combination treatments
- Market saturation leading to price compression
An understanding of these elements will be critical for stakeholders aiming for revenue optimization.
Conclusion
The market outlook for NDC 64980-0351 indicates steady growth, tempered by biosimilar competition and evolving reimbursement policies. Price projections suggest a gradual decline in list prices over the medium term, with key opportunities residing in niche indications and differentiated formulations. To harness these opportunities, stakeholders need to closely track regulatory milestones, competitive developments, and market demand shifts.
Key Takeaways
- The demand for [product name] is expected to grow at a CAGR of [percentage]%, driven by expanding indications and patient populations.
- Competitive pressures, especially from biosimilars as patent protection expires, will exert downward influence on prices.
- Current wholesale prices vary between $[X] and $[Y], but are poised for moderated decline over the next 3–5 years.
- Strategic investments in differentiation, early biosimilar development, and value-based pricing are vital for maintaining profitability.
- Regulatory and reimbursement policies represent both risks and opportunities; proactive engagement will facilitate optimal market positioning.
FAQs
1. When is the patent expiry for NDC 64980-0351, and what impact will it have?
Patent expiration is projected for [year], after which biosimilar competition is expected to increase, leading to significant price reductions and expanded market access.
2. How is the emergence of biosimilars expected to influence the pricing of this drug?
Biosimilar entry will likely reduce prices by [estimated range]%, intensifying price competition and potentially altering market share dynamics.
3. Are there upcoming regulatory changes that could impact this market?
Yes. The FDA’s enhanced pathways for biosiminlar approval and the emphasis on value-based reimbursement models are evolving factors that could affect market entry and pricing strategies.
4. What are the key market growth drivers for this drug?
Main drivers include increasing prevalence of [indications], technological advancements, and shifting treatment guidelines favoring this therapy.
5. What strategies can manufacturers adopt to maintain market profitability?
Investing in differentiated formulations, patient support programs, early biosimilar R&D, and value-based contracting will be critical for sustaining revenues amidst evolving market pressures.
References
- [Epidemiology and Demand Data], [Source]
- [Competitive Landscape Analysis], [Source]
- [Patent and Regulatory Timeline], [Source]
- [Pricing Reports], [Source]
- [Market Trend Analysis], [Source]
- [Innovation and Segmentation Opportunities], [Source]
- [Biosimilar Entry Impact Studies], [Source]
More… ↓
